Universal Technical Institute earnings missed by $0.20, revenue topped estimates
Universal Technical Institute (UTI) reported Q4 EPS of $0.32, missing estimates by $0.20, while revenue of $235.88M exceeded expectations. The company provided FY 2027 guidance, with EPS projected at $0.00-$0.09, below consensus of $1.23, and revenue expected at $925M-$945M, above consensus of $896.2M. UTI's stock is down 1.3% in 3 months and 25.2% in 12 months.
How this was made
The 30-second read
Why it matters
The combination of an EPS miss and much lower FY 2027 EPS guidance is the key trading catalyst, outweighing the modest revenue beat.
Market read
This is a direct earnings-and-guidance repricing story for UTI, with the guidance gap likely driving most of the reaction.
What to watch
The article does not break out drivers of the EPS miss (margins, enrollment, or one-offs), so traders should verify whether the guidance gap is structural or temporary.
Background
The piece is an earnings report for Universal Technical Institute, including Q4 results and FY 2027 guidance versus consensus.
Ticker impact
Universal Technical Institute reported Q4 EPS of $0.320, missing the $0.520 estimate, and issued FY 2027 EPS guidance far below consensus.
Likely downside bias as the market digests the guidance reset versus consensus.
The article provides both the earnings miss and a materially lower FY 2027 EPS range versus the stated consensus, which are direct drivers of near-term repricing.
Market effects
Weak guidance from a training/education provider can weigh on sentiment for similarly levered, cyclical education services names.
Limited, company-specific impact within US small/mid-cap equities.
Low, no cross-border or macro linkage beyond general risk appetite.
Counterpoint
Revenue topped consensus and the guidance includes a wide FY 2027 revenue range, so the market may be over-penalizing EPS if costs normalize later in the year.
Key entities
- companyUniversal Technical Institute
Reported Q4 EPS and revenue, and provided FY 2027 EPS and revenue guidance versus analyst consensus.



